Our Impact

As we reflect on the progress we have made this past year, we are reminded that none of it would be possible without the generosity and kindness of people like you.

Headshot of CDF Executive Director Dana Davis.

A Note of Thanks from Our Executive Director


Thanks to your commitment, we are able to provide life-changing support, resources, and hope to patients and families facing the daily challenges of type 1 diabetes (TID).


Whether it’s funding critical research, expanding educational programs, or helping families navigate the emotional and physical impacts of the disease, your contributions make a profound difference in the lives of those we serve and all those who love them.



Signature of Dana Davis, Executive Director of Children's Diabetes Foundation.
  • Group of smiling young T1D patients standing with medical staff at the Barbara Davis Center.

    Slide title

    Write your caption here
    Button

Our Impact in Numbers

8000+

patients being served at the Barbara Davis Center


45%

of patients at the Barbara Davis Center are uninsured or underinsured

 

35%

of patients at the Barbara Davis Center are are living at or below the poverty line


91.7%

of patients at the Barbara Davis Center are residents of Colorado


$2.1 million

raised at The 38th Carousel of Hope Ball to support the programs of CDF

Download Impact Report

Kimber Simmons, MD, Associate Professor, Pediatrics

For many patients, Tzield may delay the need for insulin by years, giving them more time without the burden of type 1 diabetes. It’s just the beginning-paving the way for even better treatments in the future. 

Rylee Arnold, Dancing with the Stars Pro & Type 1

Thank you for all of your support for the Children’s Diabetes Foundation and Barbara Davis Center for Diabetes. You are making it possible for other type 1 s to have access to life-saving care and research, and to live their lives to the fullest extent.

Lori Sussel, PhD, Research Director

The research division brings together scientific experts in autoimmunity, islet biology, insulin-producing beta cells (the cell type which is destroyed by the immune system in T1D), bioengineering, and stem cell biology to understand the root cause of T1D and develop innovative Save new therapies.